Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
J Clin Invest ; 122(12): 4685-97, 2012 Dec.
Article in English | MEDLINE | ID: mdl-23160198

ABSTRACT

Acute HIV-1 infection results in dysregulated immunity, which contributes to poor control of viral infection. DCs are key regulators of both adaptive and innate immune responses needed for controlling HIV-1, and we surmised that factors elicited during acute HIV-1 infection might impede DC function. We derived immature DCs from healthy donor peripheral blood monocytes and treated them with plasma from uninfected control donors and donors with acute HIV-1 infections. We found that the plasma from patients with HIV specifically inhibited DC function. This suppression was mediated by elevated apoptotic microparticles derived from dying cells during acute HIV-1 infection. Apoptotic microparticles bound to and inhibited DCs through the hyaluronate receptor CD44. These data suggest that targeting this CD44-mediated inhibition by apoptotic microparticles could be a novel strategy to potentiate DC activation of HIV-specific immunity.


Subject(s)
Apoptosis , Cell-Derived Microparticles/immunology , Dendritic Cells/immunology , HIV Infections/immunology , HIV-1/immunology , Hyaluronan Receptors/metabolism , Cell-Derived Microparticles/virology , Dendritic Cells/physiology , Dendritic Cells/virology , HIV Infections/blood , HIV-1/physiology , Humans , Hyaluronan Receptors/physiology , Immunity, Innate , Toll-Like Receptors/metabolism , Viremia/virology
SELECTION OF CITATIONS
SEARCH DETAIL
...